project id: TCGA-HNSC; case submitter id: TCGA-CV-A465; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.7; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.49; rna integrity number: 7.5; age at index: 24; days to birth: -9015; days to death: 215; ethnicity: hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1984; year of death: 2008; age at diagnosis: 9015; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C02.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tongue, NOS; synchronous malignancy: No; tissue or organ of origin: Tongue, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 1470; days to sample procurement: 0; initial weight: 210.0; portion submitter id: TCGA-CV-A465-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 75.0;